Non-Hodgkin's lymphoma in childhood: Clinical and epidemiological characteristics and survival analysis at a single center in Northeast Brazil;Linfoma não-Hodgkin na infância: Características clínico-epidemiológicas e avaliação de sobrevida em um único centro no Nordeste do Brasil

Jornal de Pediatria

Volumn 83, Issue 6, 2007, Pages 547-554

  Pedrosa, Márcia Ferreira ^a,b   Pedrosa, Francisco ^b,c   Lins, Mecneide M ^c   Neto, Nicodemos T Pontes ^b   Falbo, Gilliatt Hanois ^d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Cancerologia Infantil ^*

^c INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^d Escola Pernambucana de Medicina   (Brazil)

Author keywords

Cancer; Childhood; Developing countries; Epidemiology; Lymphoma; Survival

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD3 ANTIGEN; CD48 ANTIGEN; CYCLOPHOSPHAMIDE; METHOTREXATE;

ARTICLE; B LYMPHOCYTE; BRAZIL; BURKITT LYMPHOMA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PROGNOSIS; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; PROGNOSIS; SOCIOECONOMIC FACTORS;

EID: 37149003749     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1726     Document Type: Article

References (28)

1. Brasil, Ministério da Saúde. Indicadores de mortalidade. Brasília: Ministério da saúde; 2002. http://tabnet.datasus. gov.br/cgi/deftohtm.exe?idb2002/c04.def. Access: 22.06.2007.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
3. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996;334:1238-48.
4. Gutiérrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, et al. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood. 1992;79:3261-6.
5. Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991;13:222-46.
6. Sandlund JT, Fonseca T, Leimig T, Verissimo L, Ribeiro R, Lira V, et al. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia. 1997;11:743-56.
7. Bittencourt AL, Mendonça N, Cordeiro CO, Nunes CA, Bittencourt AR. Linfoma maligno não-Hodgkin na infância: estudo clínicopatológico de 70 casos. J Pediatr (Rio J). 1987;62:259-66.
8. Viana MB, Fernandes RA, de Carvalho RI, Murao M. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia. Int J Cancer Suppl. 1998;11:56-61.
9. Use and interpretation of anthropometric indicators of nutritional status. WHO Working Group. Bull World Health Organ. 1986;64:929-41.
10. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-9.
11. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphoma and L3 leukemia. Blood. 2001;97:3370-9.
12. Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 2004;104:2690-6.
13. Wollner N, Exelby PR, Lieberman PH. Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with LSA2-L2 protocol. Cancer. 1979;44:1990-9.
14. Bustamante-Texeira MT, Faerstein E, Latorre MR. Técnicas de análise de sobrevida. Cad Saude Publica. 2002;18:579-94
15. Alvim RC, Mesquita CJ, Cerqueira TA, Viana MB. Evolução dos linfomas não-Hodgkin na criança: análise do estado nutricional e de outros fatores prognósticos. J Pediatr (Rio J). 1996;72:400-10.
16. Klumb CE, Schramm MT, De Resende LM, Carriço MK, Coelho AM, de Meis EM, et al. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol. 2004;26:462-8.
17. Pedrosa F, Bonilla M, Liu A, Smith K, Davis D, Ribeiro RC, et al. Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and northern Brazil. J Pediatr Hematol Oncol. 2000;22:502-5.
18. Batista Filho M, Romani AS, organizadores. Alimentação, nutrição e saúde no estado de Pernambuco: espacialização e fatores socioeconômicos. Recife: IMIP; 2002.
19. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991;119:725-32.
20. Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, Rendón-Macías ME, Martínez-García Mdel C. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol. 2002;39:25-31.
21. Rodrigues KES. Estudo dos fatores que influenciam o atraso do diagnóstico das neoplasias malignas pediátricas dos pacientes admitidos no Hospital do Câncer de São Paulo no período de 1991 a 2002 [dissertação]. São Paulo: Fundação Antônio Prudente; 2002.
22. Reiter A, Schrappe M, Parwaresch R, Henze G, Muller-Weihrich S, Sauter S, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of Berlin-Frankfurt-Münster Group. J Clin Oncol. 1995;13:359-72.
23. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997;337:1259-66.
24. Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335-42.
25. Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416-21.
26. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 2001;97:3699-706.
27. Laver JH, Kraveka JM, Hutchison RE, Chang M, Kepner J, Schwenn M, et al. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial. J Clin Oncol. 2005;23:541-7.
28. Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004;291:2471-5.